We pointed out that the interactions between the IBT_Her2+_TNBC module (highly expressed in IBT and ER negative breast cancer) and the Her2+_TNBC module (high-expressed in ER− breast cancer) can establish a link between IBT and ER− breast cancer, so we named it “inflammation-cancer interface”. The gene discussed is ERBB2; the disease is cancer.